Advertisement
JRSS vs ORPEF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRSS is a Hold and ORPEF is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ORPEF’s FA Score shows that 1 FA rating(s) are green while.
- ORPEF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JRSS’s TA Score shows that 5 TA indicator(s) are bullish.
- JRSS’s TA Score: 5 bullish, 3 bearish.
Price Growth
ORPEF (@Medical/Nursing Services) experienced а 0.00% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.10%. For the same industry, the average monthly price growth was +0.83%, and the average quarterly price growth was -0.20%.
Industries' Descriptions
@Medical/Nursing Services (-0.10% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| JRSS | ORPEF | JRSS / ORPEF | |
| Capitalization | 23.3M | 126M | 18% |
| EBITDA | N/A | 961M | - |
| Gain YTD | -90.667 | 0.000 | - |
| P/E Ratio | 0.36 | 14.73 | 2% |
| Revenue | N/A | 4.3B | - |
| Total Cash | N/A | 952M | - |
| Total Debt | 15.5K | 12.1B | 0% |
JRSS | ORPEF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 51 Fair valued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 6 | |
PRICE GROWTH RATING 1..100 | 97 | 72 | |
P/E GROWTH RATING 1..100 | 98 | 98 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
JRSS's Valuation (51) in the null industry is in the same range as ORPEF (66). This means that JRSS’s stock grew similarly to ORPEF’s over the last 12 months.
JRSS's Profit vs Risk Rating (100) in the null industry is in the same range as ORPEF (100). This means that JRSS’s stock grew similarly to ORPEF’s over the last 12 months.
ORPEF's SMR Rating (6) in the null industry is significantly better than the same rating for JRSS (100). This means that ORPEF’s stock grew significantly faster than JRSS’s over the last 12 months.
ORPEF's Price Growth Rating (72) in the null industry is in the same range as JRSS (97). This means that ORPEF’s stock grew similarly to JRSS’s over the last 12 months.
ORPEF's P/E Growth Rating (98) in the null industry is in the same range as JRSS (98). This means that ORPEF’s stock grew similarly to JRSS’s over the last 12 months.
| JRSS | ORPEF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | N/A |
| Stochastic ODDS (%) | 2 days ago 76% | N/A |
| Momentum ODDS (%) | 2 days ago 74% | N/A |
| MACD ODDS (%) | 2 days ago 59% | N/A |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 25% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 18% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | 2 days ago 64% | N/A |
| Aroon ODDS (%) | 2 days ago 72% | N/A |
Advertisement
JRSS and
Correlation & Price change
A.I.dvisor tells us that JRSS and GBCS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JRSS and GBCS's prices will move in lockstep.
| Ticker / NAME | Correlation To JRSS | 1D Price Change % | ||
|---|---|---|---|---|
| JRSS | 100% | N/A | ||
| GBCS - JRSS | 21% Poorly correlated | N/A | ||
| SNDA - JRSS | 20% Poorly correlated | -0.33% | ||
| LTGHY - JRSS | 3% Poorly correlated | -4.44% | ||
| NVLPF - JRSS | 3% Poorly correlated | N/A | ||
| ORPEF - JRSS | 0% Poorly correlated | N/A | ||
More | ||||
ORPEF and
Correlation & Price change
A.I.dvisor tells us that ORPEF and HWAIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORPEF and HWAIF's prices will move in lockstep.
| Ticker / NAME | Correlation To ORPEF | 1D Price Change % | ||
|---|---|---|---|---|
| ORPEF | 100% | N/A | ||
| HWAIF - ORPEF | 22% Poorly correlated | -2.25% | ||
| HLYK - ORPEF | 14% Poorly correlated | -8.33% | ||
| MFCSF - ORPEF | 3% Poorly correlated | -0.79% | ||
| LWSCF - ORPEF | 2% Poorly correlated | -1.64% | ||
| RAFLF - ORPEF | 2% Poorly correlated | +7.64% | ||
More | ||||